SRI international:1110101 [19-010371]
Ended Awarded Last action
- Contract number
- 75N95019F00092
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,241,279
Award facts
- Opportunity
-
- NIHNINDS1601 Solicitation number
- Pharmacology and Toxicology for Therapeutics Program (PTTP) Award Notice · Posted Mar 4, 2016
- Contract value 100% obligated
- $2,241,279.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$226,859 | |
| Funding Only Action | -$78,789 | |
| Exercise an Option | $526,512 | |
| Exercise an Option | $517,626 | |
| Exercise an Option | $509,206 | |
| Exercise an Option | $500,852 | |
| Other Administrative Action | $0 | |
| Original award | $492,731 |
About this award
The National Institute on Drug Abuse issued a delivery order to Sri International on September 20, 2019, under the Pharmacology and Toxicology for Therapeutics Program (PTTP) IDIQ with a $2.24 million ceiling.
The PTTP is a single-award indefinite delivery vehicle supporting pharmacology and toxicology research for therapeutic drug development under the HEAL Initiative. Place of performance is Menlo Park, CA. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of September 19, 2024.
Service Contract Inventory data spanning FY2020–FY2024 shows invoiced revenue of $184 thousand (FY2020), $512 thousand (FY2021), $410 thousand (FY2022), $368 thousand (FY2023), and $516 thousand (FY2024). The most recent fiscal year (FY2024) reflects 0.7 FTEs across 1,500 contractor hours. Government-paid hourly rates trended downward from $414.33/hr in FY2021 to $220.67/hr in FY2023, recovering slightly to $344.01/hr in FY2024. Sri International self-performed all reported labor with no subcontractors reported in FY2024.
Quick answers
Who was awarded contract 75N95019F00092?
75N95019F00092 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2019.
How much is contract 75N95019F00092 worth?
The government has obligated $2,241,279 on 75N95019F00092.
Is contract 75N95019F00092 an order under another contract?
Yes. 75N95019F00092 is a delivery order under HHSN271201600006I, an indefinite delivery contract, on Pharmacology and Toxicology for Therapeutics Program (PTTP).
Was contract 75N95019F00092 competed?
The extent of competition for 75N95019F00092 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award